Secarna Pharmaceuticals

Secarna, a novel biopharmaceutical company headquartered in Munich, Germany, has developed a proprietary drug discovery platform, LNAplus, for next-generation antisense oligonucleotides. Together with partners from academia and industry, Secarna is advancing a variety of innovative antisense therapies into various stages of preclinical development across immuno-oncology, ophthalmology, immunology, fibrotic diseases (airways, liver, kidneys), and antiviral fields.